Skip to main content

and
  1. Article

    Open Access

    High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient selection

    Shien Chow, Manon Evans, Victoria Galvis in Journal for ImmunoTherapy of Cancer (2014)

  2. Article

    Open Access

    First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

    Manon Evans, Ryan Guest, Dominic Rothwell in Journal for ImmunoTherapy of Cancer (2014)